FMI Immune Checkpoint Inhibitors Market Value Share, A | Page 6

Immune Checkpoint Inhibitors Market
Asia Pacific is the fastest growing region in the immune checkpoint inhibitors market as there are number
of research collaborations of international players with companies from this region. For instance, Bristol-
Myers Squibb received Japanese approval for Opdivo in 2014, through partnership with Ono
Pharmaceuticals.
Immune Checkpoint Inhibitors Market: Key Market Participants
Some of the market contributors to the immune checkpoint inhibitors market are Bristol-Myers
Squibb, Merck & Co., Inc., Roche, AstraZeneca, Merck KGaA, Ono Pharmaceutical Co., Ltd., Novartis
International AG, Juno Therapeutics and Kite Pharma.
Browse Full Report@ http://www.futuremarketinsights.com/reports/immune-checkpoint-inhibitors-
market
©2015 Future Market Insights, All Rights Reserved
6